Medical Communications

Showing 15 posts of 6411 posts found.

microscope-275984_960_720

LifeArc rebrands and sets up £500m research fund

June 15, 2017 Medical Communications, Research and Development, Sales and Marketing LifeArc, MRC Technology, keytruda

The UK medical research charity formerly known as MRC Technology has rebranded to be known as LifeArc. At the same …
credit-_pdxnative

Trump appoints new Director of the National Cancer Institute

June 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing National Cancer Institute, appointment

Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …
1491927276280

Alexion secures ex-Biogen Chief Financial Officer

June 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, Biogen, appointment

Alexion Pharmaceuticals has announced that it has snatched up Biogen’s long-serving Chief Financial Officer Paul Clancy and will instate him …
vaccination-1215279_960_720

Bhutan and Maldives successfully eliminate measles

June 14, 2017 Medical Communications, Research and Development WHO, immunisation, measles, rubella

The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …
doug_manion

BMS vet joins Kleo Therapeutics as CEO

June 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Kleo Pharmaceutical

Kleo Pharmaceutical has moved to appoint industry veteran Doug Manion to the position of CEO. Kleo are a biotech company …
untitled

European Medicines Agency: Staying consistent in a turbulent time

June 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit

With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …
front_image

FlyPharma Conference 2017 – “Collaboration is the key”

June 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FlyPharma conference, PHARMA SUPPLY CHAIN, flypharma, supply chain

As the conference came to a conclusion, audience members were invited to offer their thoughts on what the overall message …
teva_copy

Teva conducts boardroom shuffle with four new faces

June 12, 2017 Medical Communications, Sales and Marketing

It is well-known that Teva Pharmaceutical has had a rough time of late, particularly in terms of employees. It has …
top_ten_1

Top Ten most read pages on Pharmafile.com this week

June 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

Continuous Manufacturing: Novartis’ experiment in the future of drug production

June 9, 2017 Manufacturing and Production, Medical Communications Novartis, continuous manufacturing

Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in …

Lilly bolsters diabetes assets with $55m KeyBioscience deal

June 9, 2017 Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …
actelion

Actelion spin-off hit by blow shortly before buyout

June 9, 2017 Medical Communications, Research and Development Actelion, Idorsia, J&J, JJ

Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …
fda_building

FDA calls for withdrawal of opioid product for first time in history

June 9, 2017 Medical Communications Endo pharmaceuticals, FDA, Scott Gottlieb

The FDA, since the appointment of Scott Gottlieb as commissioner, has made strong noises about tackling the opioid crisis and …
The Gateway to Local Adoption Series

Latest content